Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 40353-62-6 | MDL No. : | MFCD08692000 |
Formula : | C6H8N2OS | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | WKWHVCYMDPRLLR-UHFFFAOYSA-N |
M.W : | 156.21 | Pubchem ID : | 28065682 |
Synonyms : |
|
Num. heavy atoms : | 10 |
Num. arom. heavy atoms : | 5 |
Fraction Csp3 : | 0.33 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 41.68 |
TPSA : | 84.22 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.53 cm/s |
Log Po/w (iLOGP) : | 1.55 |
Log Po/w (XLOGP3) : | 1.02 |
Log Po/w (WLOGP) : | 1.24 |
Log Po/w (MLOGP) : | -0.39 |
Log Po/w (SILICOS-IT) : | 2.07 |
Consensus Log Po/w : | 1.1 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.76 |
Solubility : | 2.75 mg/ml ; 0.0176 mol/l |
Class : | Very soluble |
Log S (Ali) : | -2.38 |
Solubility : | 0.654 mg/ml ; 0.00419 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -1.64 |
Solubility : | 3.55 mg/ml ; 0.0227 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.4 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P280-P305+P351+P338-P310 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H332-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
1.2 g | at 100℃; for 1 h; | General procedure: To a solution of 4-bromopentane-2,3-dione (1.79 g, 10.00 mmol) in ethanol (50 mL) was added thiourea (760 mg, 9.98 mmol). The resulting solution was stirred for 1 h at 100 °C and then cooled down room temperature. The mixture was filtered to afford l-(2-amino-5-methyl-l,3-thiazol-4-yl)ethan-l-one as a off-white solid (1.2 g, 65percent). LCMS (ESI): [M+H]+ = 157.0. |
[ 36234-66-9 ]
2-Amino-6,7-dihydrobenzo[d]thiazol-4(5H)-one
Similarity: 0.89
[ 1368187-44-3 ]
1-(5-Methylthiazol-4-yl)ethanone
Similarity: 0.86
[ 101258-16-6 ]
1-(2-Aminothiazol-4-yl)ethanone
Similarity: 0.82
[ 17583-10-7 ]
2-Amino-5,6-dihydrobenzo[d]thiazol-7(4H)-one
Similarity: 0.79
[ 94284-66-9 ]
1-(4-Methyl-2-(methylamino)thiazol-5-yl)ethanone
Similarity: 0.76
[ 36234-66-9 ]
2-Amino-6,7-dihydrobenzo[d]thiazol-4(5H)-one
Similarity: 0.89
[ 482584-88-3 ]
2-Amino-5-methylthiazole-4-carbaldehyde
Similarity: 0.86
[ 101258-16-6 ]
1-(2-Aminothiazol-4-yl)ethanone
Similarity: 0.82
[ 17583-10-7 ]
2-Amino-5,6-dihydrobenzo[d]thiazol-7(4H)-one
Similarity: 0.79
[ 2933-29-1 ]
2-Amino-4,5,6,7-tetrahydrobenzothiazole
Similarity: 0.77
[ 1368187-44-3 ]
1-(5-Methylthiazol-4-yl)ethanone
Similarity: 0.86
[ 482584-88-3 ]
2-Amino-5-methylthiazole-4-carbaldehyde
Similarity: 0.86
[ 101258-16-6 ]
1-(2-Aminothiazol-4-yl)ethanone
Similarity: 0.82
[ 94284-66-9 ]
1-(4-Methyl-2-(methylamino)thiazol-5-yl)ethanone
Similarity: 0.76
[ 259654-73-4 ]
Methyl 2-(2-amino-5-methylthiazol-4-yl)acetate
Similarity: 0.75